Salivary Gland Infection Market 2018 | General Electric Company, GlaxoSmithKline plc, Merck & Co., Inc. and More Top Players by 2023

The Worldwide Salivary Gland Infection Market has been evaluated as a moderately growing market and it is expected to continue growing in the near future. Increasing prevalence of salivary gland infections are major driver for the market growth. Some other factors such as changing disease patterns, smoking, and changing environment are driving the growth of global salivary gland infection market. The market for salivary gland infection was around USD 2300.8 million in 2016 and is expected to reach USD 3622.6 million which is projected to grow at a CAGR of 6.7% by 2023.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/3779 .

Major players in Salivary Gland Infection Market:

There are plenty of large and small market players which operate in this market: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), Siemens Healthcare GmbH (Germany), and others.

Key players of this market are focusing on the development of advanced medical imaging devices for effective diagnosis of disease or disorder. Drug manufactures are investing large amount of money in new product development as well as improvement of existing product to derive efficient solution for market. Competition among the major and small players is very intense. Top players are holding majority of market share while medium and small companies are also holding small but major piece of this market.

WOCKHARDT’s a global pharmaceutical and biotechnology organization is under clinical development of its Second-generation Ketolide drug which can treat serious bacterial infections.

Salivary Gland Infection Market Segments:

Global Salivary Gland Infection Market has been segmented on the basis of diagnosis which comprises of Plain radiography, sialography, high-resolution ultrasonography, Computed tomography (CT), Magnetic Resonance Imaging (MRI), radionuclide scintigraphy, and others. Sialography is further sub-segmented into CT sialography (ultrafast technique), fluoroscopic/conventional sialography (with or without digital subtraction), and MR sialography.

On the basis of treatment, the market has been segmented into medication, surgery, aspiration, home care, and others. Medication is further sub-segmented into antibiotics and others. Antibiotics are further sub-segmented into dicloxacillin, cephalosporins, clindamycin, and others. Surgery includes removal of part of the parotid salivary gland, removal of all of the parotid salivary gland, removal of the submandibular salivary gland, and others. Home remedies include increased water intake, rest, refraining from smoking, massaging the gland with heat, and others.

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Regional analysis of global salivary gland infection market:

Considering the global scenario of the market, Americas holds the largest market share due to various factors such as increasing number of patients with various salivary gland infections and related disorders. European salivary gland infection market is the second largest where the west European countries are dominating the largest market share. Prevalence of various salivary gland infection is rising in Asia Pacific region. Additionally, increasing healthcare spending and rapidly changing healthcare sector, and government initiatives to improve public health are major growth drivers for Asia Pacific salivary gland infection market. Due to low knowledge of disease and treatments, low-income, and limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.

Key Players for Global Salivary Gland Infection Market:

Some of the key players in this market are: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), Siemens Healthcare GmbH (Germany), and others

Get Discount @ https://www.marketresearchfuture.com/check-discount/3779 .

Major Salivary Gland Infection Market Table of Content

Report Prologue
Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

Market Segmentation
Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

TOC Continued….!

Ask Questions To Expertise @ https://www.marketresearchfuture.com/enquiry/3779 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com .

This release was published on openPR.